Parkinson's disease: from genetics to treatments (Q38057859)

27 August 2017

title

Parkinson's disease: from genetics to treatments (English)

1 reference

27 August 2017

1 reference

Hueng-Chuen Fan

1

1 reference

27 August 2017

Shyi-Jou Chen

series ordinal

2

1 reference

27 August 2017

Horng-Jyh Harn

series ordinal

3

1 reference

27 August 2017

Shinn-Zong Lin

series ordinal

4

1 reference

27 August 2017

publication date

31 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

22

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

639-652

1 reference

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

LRRK2 G2019S mutation in Parkinson's disease: a neuropsychological and neuropsychiatric study in a large Algerian cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Cell replacement therapies for central nervous system disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Growth of transplanted monoaminergic neurones into the adult hippocampus along the perforant path

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Ubiquitin vinyl methyl ester binding orients the misaligned active site of the ubiquitin hydrolase UCHL1 into productive conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Interactions between metals and alpha-synuclein--function or artefact?

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Metal binding to alpha-synuclein peptides and its contribution to toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Prevalence, incidence, and mortality of PD: a door-to-door survey in Ilan county, Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Neurally induced umbilical cord blood cells modestly repair injured spinal cords.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Induction of dopaminergic neurons from growth factor expanded neural stem/progenitor cell cultures derived from human first trimester forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Lewy body pathology in fetal grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Molecular Pathways of Neurodegeneration in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Epidemiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

A femtomolar acting octapeptide interacts with tubulin and protects astrocytes against zinc intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Cell therapy in Parkinson's disease - stop or go?

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Induced pluripotent stem cells from a spinal muscular atrophy patient

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Organization of the human synphilin-1 gene, a candidate for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

NMR of alpha-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

LRRK2 expression linked to dopamine-innervated areas

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Disease-specific patterns of locus coeruleus cell loss

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Deep brain stimulation in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Formation of a functional adrenergic input to intraocular cerebellar grafts: Ingrowth of inhibitory sympathetic fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

More frequent Lewy bodies but less frequent Alzheimer-type lesions in multiple system atrophy as compared to age-matched control brains

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Efficient induction of dopaminergic neurons from embryonic stem cells for application to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Impairment of microtubule system increases alpha-synuclein aggregation and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Deciphering the role of heterozygous mutations in genes associated with parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Genetics of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Review of the functional surgical treatment of dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Mutations in NR4A2 associated with familial Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

The ubiquitin pathway in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Increased alpha-synuclein aggregation following limited cleavage by certain matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Human umbilical cord blood mononuclear cell transplantation in rats with intrinsic sphincter deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Clinical observations after neural transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Association between early-onset Parkinson's disease and mutations in the parkin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Phosphorylated α-Synuclein at Ser-129 Is Targeted to the Proteasome Pathway in a Ubiquitin-independent Manner

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Neural differentiation of human mesenchymal stem cells: Evidence for expression of neural markers and eag K+ channel types

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Phosphorylation of synucleins by members of the Polo-like kinase family

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Stable expression of a neuronal dopaminergic progenitor phenotype in cell lines derived from human amniotic fluid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1)

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Transplanted human embryonic germ cell-derived neural stem cells replace neurons and oligodendrocytes in the forebrain of neonatal mice with excitotoxic brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Glucocerebrosidase mutations in diffuse Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

G209A mutant alpha synuclein expression specifically enhances dopamine induced oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Mutations in DJ-1 are rare in familial Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

A review of Lewy body disease, an emerging concept of cortical dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

The PINK1/Parkin pathway regulates mitochondrial morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Environmental risk factors and Parkinson's disease: a metaanalysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Synucleins are a novel class of substrates for G protein-coupled receptor kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Synphilin-1 attenuates neuronal degeneration in the A53T alpha-synuclein transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

A new method for the rapid and long term growth of human neural precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Culture media for the differentiation of mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Deep brain stimulation in the treatment of severe dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Direct conversion of fibroblasts to functional neurons by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Cell transplantation and gene therapy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Phenotypic spectrum of patients with PLA2G6 mutation and PARK14 -linked parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

LRRK2G2019S as a Cause of Parkinson's Disease in North African Arabs

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X655082

21 January 2018

Identifiers

DOI

10.3727/096368912X655082

1 reference

27 August 2017

1 reference